The Role and Mechanism of Unfolded Protein Response Pathway in Tumor Drug Resistance

PAR

Proceedings of Anticancer Research

2208-35452208-3553

Bio-Byword Scientific Publishing Pty. Ltd.

10.26689/par.v7i6.5647

Article

The Role and Mechanism of Unfolded Protein Response Pathway in Tumor Drug Resistancehttps://artdesignp.com/journal/PAR/7/6/10.26689/par.v7i6.5647HanYaqi,ZhouBingjuan,QiaoHaizhi,WangLingyan,ZhangJinku

2023

2023-11-22

In the process of tumor proliferation and metastasis, tumor cells encounter hypoxia, low glucose, acidosis, and other stressful environments. These conditions prompt tumor cells to generate endoplasmic reticulum stress (ERS). As a signal mechanism that mitigates ERS in eukaryotic cells, the unfolded protein response (UPR) pathway can activate cells and tissues, regulating pathological activities in various cells, and maintaining ER homeostasis. It forms the most crucial adaptive and defensive mechanism for cells. However, under the continuous influence of chemotherapy drugs, the quantity of unfolded proteins and erroneous proteins produced by tumor cells significantly increases, surpassing the normal regulatory range of UPR. Consequently, ERS fails to function properly, fostering tumor cell proliferation and the development of drug resistance. This review delves into the study of three UPR pathways (PERK, IRE1, and ATF6), elucidating the mechanisms of drug resistance and research progress in the signal transduction pathway of UPR related to cancers. It provides a profound understanding of the role and relationship between UPR and anti-tumor drugs, offering a new direction for effective clinical treatment.

Wang L-K, Li T, Xu F-F, 2019, The Mechanism of the Unfolded Protein Response Activation. Progress in Biochemistry and Biophysics, 50(5): 877–891. https://doi.org/10.16476/j.pibb.2023.0137

Barua D, Gupta A, Gupta S, 2020, Targeting the IRE1-XBP1 Axis to Overcome Endocrine Resistance in Breast Cancer: Opportunities and Challenges. Cancer Lett, 486: 29–37. https://doi.org/10.1016/j.canlet.2020.05.020.

Read A, Schröder M, 2021, The Unfolded Protein Response: An Overview. Biology (Basel), 10(5): 384.

Ron D, Walter P, 2007, Signal Integration in the Endoplasmic Reticulum Unfolded Protein Response. Nat Rev Mol Cell Biol, 8(7): 519–529. https://doi.org/10.1038/nrm2199

Verfaillie T, Garg AD, Agostinis P, 2013, Targeting ER Stress Induced Apoptosis and Inflammation in Cancer. Cancer Lett, 332(2): 249–264. https://doi.org/10.1016/j.canlet.2010.07.016

Jiang YZ, Ma D, Suo C, et al., 2019, Genomic and Transcriptomic Landscape of Triple-Negative Breast Cancers: Subtypes and Treatment Strategies. Cancer Cell, 35(3): 428–440.e5. https://doi.org/10.1016/j.ccell.2019.02.001

Zhou X, He L, Yu R, 2012, Advances in Endoplasmic Reticulum Stress and Unfolded Protein Response Pathways. Chinese Journal of Occupational Medicine, 39(3): 264–267.

Tu J, Yang X, 2012, Research Progress of Unfolded Protein Reaction and Tumor. Journal of Jining Medical College, 35(4): 292–296.

Yan Y, He M, Wei M, 2015, Mechanisms of Endoplasmic Reticulum Stress and Drug Resistance in Tumor Cells. Chinese Journal of Pharmacology, 31(4): 461–464.

Ron D, Walter P, 2007, Signal Integration in the Endoplasmic Reticulum Unfolded Protein Response. Nat Rev Mol Cell Biol, 8(7): 519–529. https://doi.org/10.1038/nrm2199

Liu L, Guo Q, 2009, Signaling Pathway of Unfolded Protein Reaction. Chinese Journal of Pharmaceutical Biotechnology, 4(6): 455–457.

Hiramatsu N, Messah C, Han J, et al., 2014, Translational and Posttranslational Regulation of XIAP by eIF2? and ATF4 Promotes ER Stress-Induced Cell Death During the Unfolded Protein Response. Mol Biol Cell, 25(9): 1411–1420. https://doi.org/10.1091/mbc.E13-11-0664

Kania E, Pajak B, Orzechowski A, 2015, Calcium Homeostasis and ER Stress in Control of Autophagy in Cancer Cells. Biomed Res Int, 2015: 352794. https://doi.org/10.1155/2015/352794

Kouroku Y, Fujita E, Tanida I, et al., 2007, ER Stress (PERK/eIF2alpha Phosphorylation) Mediates the Polyglutamine-Induced LC3 Conversion, an Essential Step for Autophagy Formation. Cell Death Differ, 14(2): 230–239. https://doi.org/10.1038/sj.cdd.4401984

Kroemer G, Mariño G, Levine B, 2010, Autophagy and the Integrated Stress Response. Mol Cell, 40(2): 280–293. https://doi.org/10.1016/j.molcel.2010.09.023

Uppala JK, Gani AR, Ramaiah KVA, 2017, Chemical Chaperone, TUDCA Unlike PBA, Mitigates Protein Aggregation Efficiently and Resists ER and Non-ER Stress Induced HepG2 Cell Death. Sci Rep, 7(1): 3831. https://doi.org/10.1038/s41598-017-03940-1

Li P, Fu D, Sheng O, et al., 2019, TUDCA Attenuates Intestinal Injury and Inhibits Endoplasmic Reticulum StressMediated Intestinal Cell Apoptosis in Necrotizing Enterocolitis. Int Immunopharmacol, 74: 105665. https://doi.org/10.1016/j.intimp.2019.05.050

Sarvani C, Sireesh D, Ramkumar KM, 2017, Unraveling the Role of ER Stress Inhibitors in the Context of Metabolic Diseases. Pharmacol Res, 119: 412–421. https://doi.org/10.1016/j.phrs.2017.02.018

Kong Q, Wang Y, 2011, Research Progress of IRE1?-XBP1 Pathway in Tumor. Obstetrics & Gynecology (Electronic edition), 11(3): 41–45.

Amodio G, Moltedo O, Fasano D, et al., 2019, PERK-Mediated Unfolded Protein Response Activation and Oxidative Stress in PARK20 Fibroblasts. Front Neurosci, 13: 673. https://doi.org/10.3389/fnins.2019.00673

Lin H, Zhang J, Guo J, et al., 2018, Research Progress of ATF4 in Tumor. Chinese Journal of General Medicine, 16(1): 118–121 + 159.

Fu Z, 2009, Effect of ATF4 on Drug Resistance of Liver Cancer, thesis, Nankai University.

Ouyang Z, Chai S, Zhao H, et al., 2018, Advances in Endoplasmic Reticulum Stress PERK Pathway in Tumors. Journal of Practical Oncology, 32(1): 38–41.

Wortel IMN, van der Meer LT, Kilberg MS, et al., 2017, Surviving Stress: Modulation of ATF4-Mediated Stress Responses in Normal and Malignant Cells. Trends Endocrinol Metab, 28(11): 794–806. https://doi.org/10.1016/j.tem.2017.07.003

Wang H, Liu Q, 2018, ATF4 Gene and Tumor. China Medical Review, 15(18): 36–39.

Feng Y-X, Sokol ES, Gupta PB, 2014, The Endoplasmic Reticulum May be an Achilles’ Heel of Cancer Cells that Have Undergone an Epithelial-to-Mesenchymal Transition. Mol Cell Oncol, 1(2): e961822. https://doi.org/10.4161/23723548.2014.961822

Feng Y-X, Sokol ES, Del Vecchio CA, et al., 2014, Epithelial-to-Mesenchymal Transition Activates PERK-eIF2? and Sensitizes Cells to Endoplasmic Reticulum Stress. Cancer Discov, 4(6): 702–715. https://doi.org/10.1158/2159-8290.CD-13-0945

Li X, 2020, Effect of Endoplasmic Reticulum Stress on Down-Regulating Androgen Receptor Expression in LAR Type Triple Negative Breast Cancer and Its Molecular Mechanism, thesis, Chongqing Medical University.

Shi Z, Yu X, Yuan M, et al., 2019, Activation of the PERK-ATF4 Pathway Promotes Chemo-Resistance in Colon Cancer Cells. Sci Rep, 9(1): 3210. https://doi.org/10.1038/s41598-019-39547-x

Timalsina S, Arimoto-Matsuzaki K, Kitamura M, et al., 2018, Chemical Compounds that Suppress Hypoxia-Induced Stress Granule Formation Enhance Cancer Drug Sensitivity of Human Cervical Cancer HeLa Cells. J Biochem, 164(5): 381–391. https://doi.org/10.1093/jb/mvy062https://doi.org/

Madden E, Logue SE, Healy SJ, et al., 2019, The Role of the Unfolded Protein Response in Cancer Progression: From Oncogenesis to Chemoresistance. Biol Cell, 111(1): 1–17. https://doi.org/10.1111/boc.201800050

Rukia M, He X, Guo Q, 2020, Study on the Mechanism of 5-Fluorouracil Resistance Mediated by PERK Signaling Pathway in Colon Cancer Cells. Modern Oncology Medicine, 28(6): 897–901.

Gao Q, 2020, Effect of ATF4 on Autophagy Reversal of Cisplatin Resistance in Ovarian Cancer A2780/DDP Cells, thesis, Fujian Medical University.

Chen H, Zhu K, 2023, Research Progress of Unfolded Protein Reaction Involved in Chemotherapy Resistance of Pancreatic Cancer. Journal of Medical Research, 2023: 1–8.

Dekervel J, Bulle A, Windmolders P, et al., 2017, Acriflavine Inhibits Acquired Drug Resistance by Blocking the Epithelial-to-Mesenchymal Transition and the Unfolded Protein Response. Transl Oncol, 10(1): 59–69. https://doi.org/10.1016/j.tranon.2016.11.008

Cubillos-Ruiz JR, Bettigole SE, Glimcher LH, 2017, Tumorigenic and Immunosuppressive Effects of Endoplasmic Reticulum Stress in Cancer. Cell, 168(4): 692–706. https://doi.org/10.1016/j.cell.2016.12.004

Logue SE, McGrath EP, Cleary P, et al., 2018, Inhibition of IRE1 RNase Activity Modulates the Tumor Cell Secretome and Enhances Response to Chemotherapy. Nat Commun, 9(1): 3267. https://doi.org/10.1038/s41467-018-05763-8

Zhou T, Yu H, Su J, et al., 2011, Effect of Cisplatin on Endoplasmic Reticulum Stress of SKOV3 and SKOV3/DDP Cells in Human Ovarian Cancer. Chinese Journal of Experimental Diagnostics, 15(5): 809–811.

Chen X, Iliopoulos D, Zhang Q, et al., 2014, XBP1 Promotes Triple Negative Breast Cancer by Controlling the HIF1? Pathway. Nature, 508(7494): 103–107. https://doi.org/10.1038/nature13119

Ming J, Ruan S, Wang M, et al., 2015, A Novel Chemical, STF-083010, Reverses Tamoxifen-Related Drug Resistance in Breast Cancer by Inhibiting IRE1/XBP1. Oncotarget, 6(38): 40692–40703. https://doi.org/10.18632/oncotarget.5827

McMellen A, Yamamoto TM, Qamar L, et al., 2023, ATF6-Mediated Signaling Contributes to PARP Inhibitor Resistance in Ovarian Cancer. Mol Cancer Res, 21(1): 3–13. https://doi.org/10.1158/1541-7786.MCR-22-0102

Benedetti R, Romeo MA, Arena A, et al., 2022, ATF6 Prevents DNA Damage and Cell Death in Colon Cancer Cells Undergoing ER Stress. Cell Death Discov, 8(1): 295. https://doi.org/10.1038/s41420-022-01085-3